%A Qiao Yinbiao, Yang Bo %T Research progress of HGF/c-MET signaling pathway inhibitors in antipancreatic cancer %0 Journal Article %D 2017 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2017.04.017 %P 304-306 %V 44 %N 4 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10209.shtml} %8 2017-04-08 %X Pancreatic cancer is one of the most malignant tumors. Targeted therapy has become an important part of the treatment of pancreatic cancer. The signaling pathways such as hepatocyte growth factor/c-MET (HGF/c-MET) signaling pathway, inhibition of which may exerts an antitumor effect, play extremely important roles in the occurrence and development of pancreatic cancer. Therefore, the research of HGF/c-MET targeted inhibitors opens up a new avenue for treatment of pancreatic cancer.